ribociclib 200 MG Oral Tablet

RxCUI: 1873983
RxNorm name: ribociclib 200 MG Oral Tablet
Display name: ribociclib 200 MG Oral Tablet
Full name: ribociclib 200 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KISQALI	RIBOCICLIB	Novartis Pharmaceuticals Corporation	aaeaef94-f3f5-4367-8ea2-b181d7be2da8	2026-07-01	Warnings, Adverse reactions	Exact identifier rxcui: 1873983
KISQALI FEMARA CO-PACK	LETROZOLE AND RIBOCICLIB	Novartis Pharmaceuticals Corporation	aa5e4446-19cd-4235-a382-5b48bf6c3b2f	2026-07-01	Warnings, Adverse reactions	Exact identifier rxcui: 1873983

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	ribociclib 200 MG Oral Tablet	PSN	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	ribociclib 200 MG Oral Tablet	SCD	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215
aaeaef94-f3f5-4367-8ea2-b181d7be2da8	ribociclib 200 MG (equivalent to ribociclib succinate 254.4 MG) Oral Tablet	SY	27	These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI ® (ribociclib) tablets, for oral use Initial U.S. Approval: 2017	20251215
aa5e4446-19cd-4235-a382-5b48bf6c3b2f	ribociclib 200 MG Oral Tablet	SCD	25	These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 2017	20250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2f	ribociclib 200 MG (equivalent to ribociclib succinate 254.4 MG) Oral Tablet	SY	25	These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 2017	20250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2f	ribociclib 200 MG Oral Tablet	PSN	25	These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 2017	20250916